On October 23, 2017, Taiwan’s Food and Drug Administration (TFDA) announced a new online platform to speed up the registration and review time for pharmaceutical products. Until now, pharmaceutical companies had to mail the necessary documents in paper and in electronic copies stored on CDs. The TFDA also required the documents in CTD format, which can be converted through its website. Under the new online platform, called E-PRESS, companies can upload their documents through their own accounts and pay the review fee online.
